Axsome gets US FDA approval for Auvelity to treat MDD in adults
US-based biopharmaceutical company Axsome Therapeutics has secured the US Food and Drug Administration (FDA) approval for Auvelity to treat major depressive disorder (MDD) in adults. Auvelity is a